Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$775.18 - $881.7 $324 Million - $369 Million
-418,349 Reduced 99.94%
232 $203,000
Q3 2023

Nov 09, 2023

SELL
$692.45 - $844.37 $1.32 Million - $1.6 Million
-1,900 Reduced 0.45%
418,581 $344 Million
Q2 2023

Aug 08, 2023

SELL
$700.03 - $830.35 $8.76 Million - $10.4 Million
-12,516 Reduced 2.89%
420,481 $302 Million
Q1 2023

May 11, 2023

SELL
$680.49 - $826.97 $12,248 - $14,885
-18 Reduced -0.0%
432,997 $356 Million
Q1 2023

May 09, 2023

BUY
$680.49 - $826.97 $379,713 - $461,449
558 Added 0.13%
433,015 $356 Million
Q4 2022

May 12, 2023

SELL
$705.89 - $766.39 $332,474 - $360,969
-471 Reduced 0.11%
432,526 $312 Million
Q4 2022

Jan 30, 2023

BUY
$705.89 - $766.39 $305 Million - $331 Million
432,457 New
432,457 $312 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $11.3 Million - $14.2 Million
-19,631 Reduced 3.82%
493,883 $340 Million
Q2 2022

Aug 11, 2022

BUY
$548.35 - $738.84 $46.6 Million - $62.8 Million
85,039 Added 19.85%
513,514 $304 Million
Q1 2022

May 10, 2022

SELL
$595.12 - $698.43 $289 Million - $339 Million
-485,705 Reduced 53.13%
428,475 $299 Million
Q4 2021

Feb 10, 2022

SELL
$543.48 - $670.97 $56.7 Million - $70 Million
-104,274 Reduced 10.24%
914,180 $577 Million
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $75 Million - $88.9 Million
130,619 Added 14.71%
1,018,454 $616 Million
Q2 2021

Aug 10, 2021

BUY
$472.8 - $558.54 $45.4 Million - $53.6 Million
95,947 Added 12.12%
887,835 $496 Million
Q1 2021

May 10, 2021

BUY
$446.73 - $548.2 $48.6 Million - $59.6 Million
108,744 Added 15.92%
791,888 $375 Million
Q4 2020

Feb 04, 2021

BUY
$478.3 - $607.98 $107 Million - $136 Million
223,097 Added 48.49%
683,144 $330 Million
Q3 2020

Nov 10, 2020

SELL
$544.75 - $658.21 $34.5 Million - $41.7 Million
-63,344 Reduced 12.1%
460,047 $258 Million
Q2 2020

Aug 10, 2020

BUY
$493.32 - $643.92 $27.3 Million - $35.6 Million
55,353 Added 11.83%
523,391 $326 Million
Q1 2020

May 07, 2020

SELL
$336.18 - $494.43 $73.2 Million - $108 Million
-217,793 Reduced 31.76%
468,038 $229 Million
Q4 2019

Feb 04, 2020

SELL
$274.13 - $376.51 $18.5 Million - $25.4 Million
-67,416 Reduced 8.95%
685,831 $258 Million
Q3 2019

Nov 13, 2019

BUY
$273.46 - $318.39 $5.57 Million - $6.49 Million
20,376 Added 2.78%
753,247 $209 Million
Q2 2019

Aug 12, 2019

SELL
$299.6 - $414.82 $56.2 Million - $77.8 Million
-187,551 Reduced 20.38%
732,871 $229 Million
Q1 2019

May 10, 2019

SELL
$372.08 - $439.57 $3.34 Million - $3.94 Million
-8,969 Reduced 0.97%
920,422 $378 Million
Q4 2018

Feb 06, 2019

SELL
$335.82 - $403.04 $22.3 Million - $26.7 Million
-66,346 Reduced 6.66%
929,391 $347 Million
Q3 2018

Nov 07, 2018

SELL
$351.14 - $408.51 $4.93 Million - $5.74 Million
-14,047 Reduced 1.39%
995,737 $402 Million
Q2 2018

Aug 10, 2018

SELL
$284.6 - $344.99 $10.3 Million - $12.5 Million
-36,126 Reduced 3.45%
1,009,784 $348 Million
Q1 2018

May 09, 2018

BUY
$315.82 - $393.78 $51.8 Million - $64.6 Million
163,981 Added 18.59%
1,045,910 $360 Million
Q4 2017

Feb 13, 2018

BUY
$358.63 - $469.95 $76.9 Million - $101 Million
214,428 Added 32.12%
881,929 $332 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $288 Million - $336 Million
667,501
667,501 $298 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Sustainable Growth Advisers, LP Portfolio

Follow Sustainable Growth Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sustainable Growth Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sustainable Growth Advisers, LP with notifications on news.